JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Shares Down 0.2% – Here’s What Happened

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) shares traded down 0.2% on Friday . The company traded as low as $57.57 and last traded at $57.57. 805 shares traded hands during mid-day trading, a decline of 10% from the average session volume of 895 shares. The stock had previously closed at $57.67.

JPMorgan Healthcare Leaders ETF Stock Down 0.2%

The stock has a market capitalization of $11.51 million, a PE ratio of 22.43 and a beta of 0.44. The business’s 50-day moving average is $56.01 and its two-hundred day moving average is $57.20.

Institutional Investors Weigh In On JPMorgan Healthcare Leaders ETF

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Ignite Planners LLC lifted its position in JPMorgan Healthcare Leaders ETF by 136.8% in the fourth quarter. Ignite Planners LLC now owns 9,460 shares of the company’s stock valued at $553,000 after acquiring an additional 5,465 shares during the last quarter. Blue Water Asset Management purchased a new stake in JPMorgan Healthcare Leaders ETF in the fourth quarter valued at $237,000. Sanctuary Advisors LLC lifted its position in JPMorgan Healthcare Leaders ETF by 12.7% in the fourth quarter. Sanctuary Advisors LLC now owns 6,359 shares of the company’s stock valued at $368,000 after acquiring an additional 718 shares during the last quarter. Krilogy Financial LLC purchased a new stake in JPMorgan Healthcare Leaders ETF in the third quarter valued at $325,000. Finally, Jane Street Group LLC purchased a new stake in JPMorgan Healthcare Leaders ETF in the second quarter valued at $1,166,000.

JPMorgan Healthcare Leaders ETF Company Profile

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.